Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Contingent Liabilities

    Back to Balance Sheet
AD     Remove this Ad

BLISS GVS PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹59 Cr₹57 Cr₹12 Cr₹23 Cr₹30 Cr

What is the latest Contingent Liabilities ratio of BLISS GVS PHARMA ?

The latest Contingent Liabilities ratio of BLISS GVS PHARMA is ₹59 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹59 Cr
Mar2024₹57 Cr
Mar2023₹12 Cr
Mar2022₹23 Cr
Mar2021₹30 Cr

How is Contingent Liabilities of BLISS GVS PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹59 Cr
3.45
Mar2024 ₹57 Cr
390.81
Mar2023 ₹12 Cr
-48.95
Mar2022 ₹23 Cr
-25.09
Mar2021 ₹30 Cr -

Compare Contingent Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹2,149.9 Cr -0.6% -5.2% 67.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-0.6%

-5.2%

67.4%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses